Mary Bourke

Mary Bourke

Womble Bond Dickinson

Contact
View Bio
RSS

Latest Posts › Pharmaceutical Industry

Share:

Navigating the Implications of In re Cellect: What You Need to Know About Patent Term Adjustment & Obviousness-Type Double...

On January 19, 2024, the Court of Appeals for the Federal Circuit issued an order denying the Petition for Rehearing En Banc in the much awaited In re Cellect matter. The mandate of the court issued today....more

1/29/2024  /  Obviousness , Obviousness-Type Double Patenting (ODP) , Patent Litigation , Patent Term Adjustment , Patent Term Extensions , Patents , Pharmaceutical Industry , Pharmaceutical Patents , USPTO
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide